AHRQ Exhibits and Narrative
Budget Estimates for Appropriations Committees, Fiscal Year 2010
Appropriation Language—Agency for Healthcare Research and Quality
For carrying out Titles III and IX of the Public Health Service Act ("PHS ACT"), part A of Title XI of the Social Security Act, and section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, amounts received from Freedom of Information Act fees, reimbursable and interagency agreements, and the sale of data shall be credited to this appropriation and shall remain available until expended. Provided, That the amount made available pursuant to section 937(c) of the Public Health Service Act shall not exceed $372,053,000.
Amounts Available for Obligation1
Department of Health and Human Services, Agency for Healthcare Research and Quality
| Obligations | 2008 Actual2 | Appropriated 2009 | 2010 President's Budget (PB) | |
|---|---|---|---|---|
| Appropriation: | Supplemental (P.L. 111-5)3 | $0 | $1,100,000,000 | $0 |
| Transfer of Funds to NIH | $0 | -$400,000,000 | $0 | |
| Subtotal, adjusted appropriation | $0 | $700,000,000 | $0 | |
| Offsetting Collections from: Federal funds pursuant to Title IX of P.L. 102-410, (Section 937(c) PHS Act) | HCQO | $276,356,000 | $314,053,000 | $314,053,000 |
| MEPS | $55,300,000 | $55,300,000 | $55,300,000 | |
| Program Support | $2,696,000 | $2,700,000 | $2,700,000 | |
| Subtotal, adjusted appropriation | $334,352,000 | $372,053,000 | $372,053,000 | |
| Unobligated Balance Lapsing | $212,000 | - | - | |
| Total obligations | $334,564,000 | $1,072,053,000 | $372,053,000 | |
1 Excludes the following amounts for reimbursements:
FY 2008: $25,529,000 ($7,820,000 for National Research Service Awards [NRSAs] and $17,709,000 for other reimbursements).
FY 2009: $25,529,000 ($7,820,0000 for NRSAs and $17,709,000 for other reimbursements).
FY 2010: $25,529,000 ($7,820,000 for NRSAs and $17,709,000 for other reimbursements).
2 Reflects actual obligations.
3 In FY 2009, the American Recovery and Reinvestment Act (ARRA) provided $1,100,000,000 for Comparative Effectiveness Research. Of this total, $400,000,000 was transferred to the National Institute of Health. A total of $400,000,000 is available for Comparative Effectiveness Research to be allocated at the discretion of the Secretary of the Department of Health and Human Services. A new Federal Coordinating Council for Comparative Effectiveness Research will help set the agenda for these funds. The remaining $300,000,000 is available for the AHRQ to conduct and support comparative effectiveness research. These funds are available for obligation in FY 2009 and FY 2010.
Summary of Changes
2009 Appropriation: $-0-
(Obligations): (372,053,000)
2010 Estimate: $-0-
(Obligations): (372,053,000)
Net change: $-0-
(Obligations): (0)
| Changes | 2009 Current Budget Base | Change from Base | ||||
|---|---|---|---|---|---|---|
| Full Time Equivalent (FTE) | Budget Authority | (FTE) | Budget Authority | |||
| Increases | A. Built-in | 1. Annualization of 2009 pay raise | -- (--) | -- (43,037,000) | -- (--) | -- (+456,000) |
| 2. January 2010 Pay Raise | -- (--) | -- (43,037,000) | -- (--) | -- (+1,416,,000) | ||
| 3. Rental payments to General Services Administration (GSA) | -- (--) | -- (4,285,000) | -- (--) | -- (+106,000) | ||
| 6. Inflation Costs on Other Objects | -- (--) | -- (+500,000) | ||||
| Subtotal, Built-in | -- (--) | -- (+2,478,000) | ||||
| B. Program | Subtotal, Program | -- (--) | -- (--) | |||
| Total Increases | -- (+1) | -- (+2,478,000) | ||||
| Decreases | A. Built-in | 1. HCQO: Crosscutting Activities Related to Quality, Effectiveness and Efficiency—Research Grants | -- -- | - $39,602,000 | -- (--) | -- (-2,478,000) |
| Subtotal, Built-in | -- (--) | -- (-2,478,000) | ||||
| B. Program | Total, Decreases | (--) (--) | -- (-2,478,000) | |||
| Net change, Budget Authority Net change, Obligations | -- (--) | -- (--) | ||||
Budget Authority (BA) by Activity1
(Dollars in Thousands)
| Activity | 2008 | 2009 Omnibus | 2009 Recovery Act2 | 2010 | ||||
|---|---|---|---|---|---|---|---|---|
| FTE | Amount | FTE | Amount | FTE | Amount | FTE | Amount | |
| 1. Research on Health Costs, Quality, & Outcomes BA | - | 0 | - | 0 | - | 700,000 | 38 | 0 |
| PHS Evaluation | [278] | [276,564] | [278] | [314,053] | [--] | [0] | [278] | [314,053] |
| Total Operational Level | 278 | 276,564 | 278 | 314,053 | 700,000 | 316 | 314,053 | |
| 2. Medical Expenditure Panel Surveys BA | - | - | - | - | - | - | - | - |
| PHS Evaluation | - | [55,300] | - | [55,300] | - | [0] | - | [55,300] |
| Total Operational Level | - | 55,300 | - | 55,300 | - | 0 | 55,300 | |
| 3. Program Support BA | - | - | - | - | - | - | - | - |
| PHS Evaluation | [22] | [2,700] | [22] | [2,700] | [--] | [0] | [22] | [2,700] |
| Total Operational Level | 22 | 2,700 | 22 | 2,700 | - | 0 | 22 | 2,700 |
| Total, Budget Authority | 0 | 0 | 0 | 0 | - | 700,000 | 38 | 0 |
| Total PHS Evaluation | [300] | [334,564] | [300] | [372,053] | [--] | [0] | [300] | [372,053] |
| Total Operations | 300 | 334,564 | 300 | 372,053 | 700,000 | 338 | 372,053 | |
1 Excludes the following amounts for reimbursements:
FY 2008: $25,529,000 ($7,820,000 for National Research Service Awards [NRSAs] and $17,709,000 for other reimbursements).
FY 2009: $25,529,000 ($7,820,0000 for NRSAs and $17,709,000 for other reimbursements).
FY 2010: $25,529,000 ($7,820,000 for NRSAs and $17,709,000 for other reimbursements).
2In FY 2009, the American Recovery and Reinvestment Act (ARRA) provided $1,100,000,000 for Comparative Effectiveness Research. Of this total, $400,000,000 was transferred to the National Institute of Health. A total of $400,000,000 is available for Comparative Effectiveness Research to be allocated at the discretion of the Secretary of the Department of Health and Human Services. A new Federal Coordinating Council for Comparative Effectiveness Research will help set the agenda for these funds. The remaining $300,000,000 is available for the AHRQ to conduct and support comparative effectiveness research. These funds are available for obligation in FY 2009 and FY 2010. The number of FTE in FY 2010 includes an estimated 38 non-permanent FTEs to be compensated using Recovery Act funds.
Authorizing Language1
| Legislation | 2009 Amount Authorized | 2009 Omnibus | 2010 Amount Authorized | FY 2010 President's Budget |
|---|---|---|---|---|
| Research on Health Costs, Quality, and Outcomes: Secs. 301 & 926(a) Public Health Service Act (PHSA) | SSAN | $0 | SSAN | $0 |
| Research on Health Costs, Quality, and Outcomes: Part A of Title XI of the Social Security Act (SSA) Section 1142(i)2,3 Budget Authority (BA)______ Medicare Trust Funds (MTF)4,3 Subtotal BA & MTF______ | Expired5 | Expired5 | ||
| Program Support: Section 301 PHSA | Indefinite | $0 | Indefinite | $0 |
| Evaluation Funds: Section 937(c) PHSA | Indefinite | $372,053,000 | Indefinite | $372,053,000 |
| Total appropriations | $372,053,000 | $372,053,000 | ||
| Total appropriation against definite authorizations | - | - | - | - |
Note: SSAN = Such Sums As Necessary.
1. Section 487(d)(3)(B) PHSA makes one percent of the funds appropriated to the National Institutes of Health (NIH) for National Research Service Awards (NRSA) available to AHRQ. Because these reimbursable funds are not included in AHRQ's appropriation language, they have been excluded from this table.
2. Pursuant to Section 1142 of the Social Security Act, FY 1997 funds for the medical treatment effectiveness activity are to be appropriated against the total authorization level in the following manner: 70% of the funds are to be appropriated from Medicare Trust Funds (MTF); 30% of the funds are to be appropriated from general budget authority.
3. No specific amounts are authorized for years following FY 1994.
4. Funds appropriated against Title XI of the Social Security Act authorization are from the Federal Hospital Insurance Trust Funds (60%) and the Federal Supplementary Medical Insurance Trust Funds (40%).
5. Expired September 30, 1994.
Appropriations History Table
| Year | Budget Estimates to Congress | House Allowance | Senate Allowance | Appropriation | |
|---|---|---|---|---|---|
| 2001 | Budget Authority | $-0- | $123,669,000 | $-0- | $104,963,000 |
| PHS Evaluation Funds | 249,943,000 | 99,980,000 | 269,943,000 | 164,980,000 | |
| Total | $249,943,000 | $223,649,000 | $269,943,000 | $269,943,000 | |
| Rescission | Budget Authority | $-0- | $123,669,000 | $-0- | $104,816,000 |
| PHS Evaluation Funds | 249,943,000 | 99,980,000 | 269,943,000 | 164,980,000 | |
| Total | $249,943,000 | $223,649,000 | $269,943,000 | $269,796,000 | |
| 2002 | Budget Authority | $-0- | $168,445,000 | $291,245,000 | $2,600,000 |
| PHS Evaluation Funds | 306,245,000 | 137,800,000 | -0- | 296,145,000 | |
| Total | $306,245,000 | $306,245,000 | $291,245,000 | $298,745,000 | |
| 2003 | Budget Authority | $-0- | $202,645,000 | $-0- | |
| PHS Evaluation Funds | 250,000,000 | 106,000,000 | 303,695,000 | ||
| Bioterrorism | -0- | 5,000,000 | 5,000,000 | ||
| Total | $250,000,000 | $0 | $313,645,000 | $308,695,000 | |
| 2004 | Budget Authority | $-0- | $-0- | $-0- | $-0- |
| PHS Evaluation Funds | 279,000,000 | 303,695,000 | 303,695,000 | 318,695,000 | |
| Total | $279,000,000 | $303,695,000 | $303,695,000 | $318,695,000 | |
| 2005 | Budget Authority | $-0- | $-0- | $-0- | $-0- |
| PHS Evaluation Funds | 303,695,000 | 303,695,000 | 318,695,000 | 318,695,000 | |
| Total | $303,695,000 | $303,695,000 | $318,695,000 | $318,695,000 | |
| 2006 | Budget Authority | $-0- | $318,695,000 | $ | $ |
| PHS Evaluation Funds | $318,695,000 | $-0- | $323,695,000 | $318,692,000 | |
| Total | $318,695,000 | $318,695,000 | $323,695,000 | $318,692,000 | |
| 2007 | Budget Authority | $-0- | $-0- | $-0- | $-0- |
| PHS Evaluation Funds | $318,692,000 | $-0- | $-0- | $318,692,000 | |
| Total | $318,692,000 | $-0- | $-0- | $318,692,000 | |
| 2008 | Budget Authority | $-0- | $329,564,000 | $329,564,000 | $-0- |
| PHS Evaluation Funds | $329,564,000 | $-0- | $-0- | $334,564,000 | |
| Total | $329,564,000 | $329,564,000 | $329,564,000 | $334,564,000 | |
| 2009 | Budget Authority | $-0- | $323,087,000 | $90,598,000 | $-0- |
| PHS Evaluation Funds | $325,664,000 | 51.913,000 | 243,966,000 | $372,053,000 | |
| ARRA Funding P.L. 111-5 | $-0- | $-0- | $-0- | $1,100,000,0001 | |
| Total | $325,664,000 | $375,000,000 | $334,564,000 | $1,472,053,000 | |
| 2010 | Budget Authority | $-0- | |||
| PHS Evaluation Funds | $372,053,000 | ||||
| Total | $372,053,000 | ||||
1 In FY 2009, the American Recovery and Reinvestment Act (ARRA) provided $1,100,000,000 for Comparative Effectiveness Research. Of this total, $400,000,000 was transferred to the National Institute of Health. A total of $400,000,000 is available for Comparative Effectiveness Research to be allocated at the discretion of the Secretary of the Department of Health and Human Services. A new Federal Coordinating Council for Comparative Effectiveness Research will help set the agenda for these funds. The remaining $300,000,000 is available for the AHRQ to conduct and support comparative effectiveness research. These funds are available for obligation in FY 2009 and FY 2010.
5600 Fishers Lane Rockville, MD 20857